Spectral Med Stock Buy Hold or Sell Recommendation
| EDT Stock | CAD 0.57 0.02 3.64% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Spectral Med is 'Not Rated'. The recommendation algorithm takes into account all of Spectral Med's available fundamental, technical, and predictive indicators you will find on this site.
Check out Spectral Med Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Spectral and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Spectral Med. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Spectral |
Execute Spectral Med Buy or Sell Advice
The Spectral recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Spectral Med. Macroaxis does not own or have any residual interests in Spectral Med or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Spectral Med's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Spectral Med Trading Alerts and Improvement Suggestions
| Spectral Med generated a negative expected return over the last 90 days | |
| Spectral Med has some characteristics of a very speculative penny stock | |
| Spectral Med has high historical volatility and very poor performance | |
| Spectral Med has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.6 M. Net Loss for the year was (15.66 M) with profit before overhead, payroll, taxes, and interest of 983 K. | |
| Spectral Med has accumulated about 3.8 M in cash with (10.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 18.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Spectral AIs Military Medical Device Advances with 7.2M Govt Funding, FDA Breakthrough Status MDAI Stock News - StockTitan |
Spectral Med Returns Distribution Density
The distribution of Spectral Med's historical returns is an attempt to chart the uncertainty of Spectral Med's future price movements. The chart of the probability distribution of Spectral Med daily returns describes the distribution of returns around its average expected value. We use Spectral Med price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Spectral Med returns is essential to provide solid investment advice for Spectral Med.
| Mean Return | -0.2 | Value At Risk | -6.45 | Potential Upside | 5.08 | Standard Deviation | 3.59 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Spectral Med historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Spectral Med Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (2.9M) | 4.4M | 3.1M | (476K) | (5.5M) | (5.2M) | |
| Free Cash Flow | (2.9M) | (639K) | (9.2M) | (10.0M) | (10.9M) | (11.5M) | |
| Depreciation | 278K | 304K | 294K | 272K | 218K | 207.1K | |
| Other Non Cash Items | 36K | 32K | 28K | (806K) | 3.6M | 3.8M | |
| Capital Expenditures | 161K | 315K | 483K | 33K | 185K | 175.8K | |
| Net Income | (4.9M) | (9.1M) | (8.8M) | (11.3M) | (15.7M) | (14.9M) | |
| End Period Cash Flow | 1.4M | 5.8M | 8.9M | 8.4M | 3.0M | 5.8M | |
| Change To Inventory | (79K) | (72K) | (51K) | (47K) | (26K) | (27.3K) | |
| Investments | (161K) | (297K) | (325K) | (33K) | (185K) | (175.8K) | |
| Change To Netincome | 722K | 1.1M | 1.5M | 391K | 449.7K | 675.4K |
Spectral Med Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Spectral Med or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Spectral Med's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Spectral stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | -0.58 | |
σ | Overall volatility | 3.62 | |
Ir | Information ratio | -0.09 |
Spectral Med Volatility Alert
Spectral Med exhibits very low volatility with skewness of -0.08 and kurtosis of 0.24. Spectral Med is a potential penny stock. Although Spectral Med may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Spectral Med. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Spectral instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Spectral Med Fundamentals Vs Peers
Comparing Spectral Med's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Spectral Med's direct or indirect competition across all of the common fundamentals between Spectral Med and the related equities. This way, we can detect undervalued stocks with similar characteristics as Spectral Med or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Spectral Med's fundamental indicators could also be used in its relative valuation, which is a method of valuing Spectral Med by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Spectral Med to competition |
| Fundamentals | Spectral Med | Peer Average |
| Return On Equity | -9.74 | -0.31 |
| Return On Asset | -0.93 | -0.14 |
| Operating Margin | (9.46) % | (5.51) % |
| Current Valuation | 163.21 M | 16.62 B |
| Shares Outstanding | 282.82 M | 571.82 M |
| Shares Owned By Insiders | 18.13 % | 10.09 % |
| Shares Owned By Institutions | 12.95 % | 39.21 % |
| Number Of Shares Shorted | 95.22 K | 4.71 M |
| Price To Earning | (16.07) X | 28.72 X |
| Price To Book | 49.87 X | 9.51 X |
| Price To Sales | 84.80 X | 11.42 X |
| Revenue | 1.6 M | 9.43 B |
| Gross Profit | 983 K | 27.38 B |
| EBITDA | (13.96 M) | 3.9 B |
| Net Income | (15.66 M) | 570.98 M |
| Cash And Equivalents | 3.8 M | 2.7 B |
| Cash Per Share | 0.02 X | 5.01 X |
| Total Debt | 8.56 M | 5.32 B |
| Debt To Equity | 16.30 % | 48.70 % |
| Current Ratio | 6.95 X | 2.16 X |
| Book Value Per Share | (0.06) X | 1.93 K |
| Cash Flow From Operations | (10.72 M) | 971.22 M |
| Short Ratio | 1.04 X | 4.00 X |
| Earnings Per Share | (0.10) X | 3.12 X |
| Target Price | 2.0 | |
| Number Of Employees | 29 | 18.84 K |
| Beta | 1.0 | -0.15 |
| Market Capitalization | 161.2 M | 19.03 B |
| Total Asset | 5.21 M | 29.47 B |
| Retained Earnings | (125.44 M) | 9.33 B |
| Working Capital | (6.12 M) | 1.48 B |
| Net Asset | 5.21 M |
Spectral Med Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Spectral . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Spectral Med Buy or Sell Advice
When is the right time to buy or sell Spectral Med? Buying financial instruments such as Spectral Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Spectral Med in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rentals Thematic Idea Now
Rentals
Companies providing rental and leasing services to public and business. The Rentals theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Spectral Stock
Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.